ARCHIVES

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

UICC Names Banker As Chief Executive

September 11, 2009

Charges Against CC Probed; Most Found Invalid

March 31, 1978

In Brief: MB Ends Apportionment Carlo Croce To Head Fels Institute, Replacing Peter Magee Sept. 1

March 4, 1988

NCI Advisory Group, Other Cancer Meetings For April, May

March 26, 1976

Increase In DCCR Grants May Not Be Possible Without Decreasing Quality, Committee Told

July 28, 1978

Cancer Advocacy: March On Washington Scheduled For September 1998

October 31, 1997